Verify analytical purity and lot integrity for GHK-Cu research compounds. PX1 Research provides comprehensive, third-party lot-specific Certificate of Analysis (COA) reports, including High-Performance Liquid Chromatography (HPLC), Mass Spectrometry (MS), and endotoxin testing for all laboratory reagents.
Verify analytical purity and lot integrity for GHK-Cu research compounds. PX1 Research provides comprehensive, third-party lot-specific Certificate of Analysis (COA) reports, including High-Performance Liquid Chromatography (HPLC), Mass Spectrometry (MS), and endotoxin testing for all laboratory reagents.
A GHK-Cu certificate of analysis (COA) is an official analytical document provided by an independent, ISO 17025-accredited laboratory that verifies the identity, purity, and safety profile of a specific lot of Glycyl-L-histidyl-L-lysine copper complex. A valid ghk-cu coa confirms peptide purity—typically exceeding 99% via High-Performance Liquid Chromatography (HPLC)—and validates molecular weight using Mass Spectrometry (MS) alongside quantified bacterial endotoxin levels.
For investigators conducting preclinical assays, obtaining a verifiable ghk cu coa is essential to ensure experimental reproducibility and rule out contaminants that could skew biological data. Every batch of GHK-Cu research compound distributed by PX1 Research undergoes rigorous testing, ensuring lot-traceable verification before release to institutional laboratories.
Evaluating a ghk-cu-coa requires analyzing several key analytical metrics that confirm compound integrity. When reviewing analytical documentation from high-purity research peptides, research teams must verify the presence and precision of the following core analytical parameters:
1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): RP-HPLC separates the primary peptide sequence from synthesis byproducts, truncated sequences, or uncoordinated copper ions. The resulting chromatogram displays a dominant peak representing GHK-Cu, with peak area integration establishing exact purity percentages.
2. Electrospray Ionization Mass Spectrometry (ESI-MS): ESI-MS confirms the exact monoisotopic mass and coordination structure of the tripeptide-copper complex. The observed mass peak must match the theoretical molecular weight of GHK-Cu (monoisotopic mass approximately 340.38 g/mol for the free base sequence, plus coordinated copper II ion).
3. Endotoxin Testing (LAL Assay): Bacterial endotoxins (lipopolysaccharides) can induce unwanted inflammatory signaling in cellular and animal models. A robust ghk-cu certificate of analysis specifies endotoxin levels quantified in Endotoxin Units per milligram (EU/mg), typically demonstrating values far below standard limits (<0.5 EU/mg).
4. Appearance and Solubility Verification: Physical observation logs record the visual form—typically a distinct blue lyophilized powder—and confirm complete solubility in sterile aqueous media prior to assay preparation.
To maintain rigorous research standards, PX1 Research applies strict quality thresholds across all batches. Below is the standard testing framework applied to our GHK-Cu reagent lots:
• Chemical Name: Glycyl-L-histidyl-L-lysine copper complex (GHK-Cu) • Purity Specification: ≥99.0% determined by RP-HPLC peak area integration • Molecular Weight Verification: Confirmed via ESI-MS ([M+H]+ and complexed ion species) • Endotoxin Quantification: <0.1 to <0.5 EU/mg via Chromogenic LAL Assay • Manufacturing Standards: Produced in GMP-compliant facilities within the United States • Facility Accreditation: Analytical testing performed by independent ISO 17025 accredited laboratories • Storage and Distribution: Lyophilized stock dispatched same-day (M–F) from California and Arizona distribution hubs
By enforcing these rigorous criteria, researchers are guaranteed a stable, contamination-free compound suitable for sensitive in vitro, cell culture, and preclinical animal research models. Broader technical data on peptide quality standards can be explored in the PX1 Research Library.
GHK-Cu is a naturally occurring human plasma copper-binding tripeptide originally identified for its high affinity for copper(II) ions and broad biological activity. In preclinical models, GHK-Cu acts as a signal peptide and carrier molecule, modulating the transcription of genes involved in cellular matrix turnover and tissue repair.
In vitro assays demonstrate that GHK-Cu stimulates collagen and elastin synthesis in human dermal fibroblasts, enhancing structural protein expression while balancing matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs). Animal studies suggest that local administration of GHK-Cu accelerates wound closure, promotes angiogenesis, and reduces fibrotic scarring through regulated extracellular matrix remodeling.
In addition to extracellular matrix regulation, preclinical literature indicates that GHK-Cu possesses anti-inflammatory and antioxidant activities. It quashes lipid peroxidation products and modulates pro-inflammatory cytokine expression (such as TNF-alpha and IL-6) in cultured cell lines, making it a pivotal subject in tissue engineering and regenerative medicine studies.
When designing tissue remodeling or extracellular matrix research protocols, investigators often compare GHK-Cu to other key signal peptides and repair factors. Understanding the distinct mechanisms and analytical profiles of these compounds helps optimize experimental design.
For instance, while GHK-Cu directly modulates copper transport, collagen deposition, and matrix remodeling, the synthetic pentadecapeptide BPC-157 operates primarily through VEGFR2 pathway upregulation and nitric oxide modulation to promote tendon, ligament, and mucosal healing. Similarly, TB-500 (Thymosin Beta-4 fragment) functions via actin sequestration and cell migration signaling. For dermal matrix research, Palmitoyl Tripeptide-1 is frequently analyzed alongside GHK-Cu to compare lipophilic signal peptides against copper-coordinated complexes. Reviewing a verified ghk-cu coa alongside COAs for these complementary compounds ensures baseline purity and prevents confounding variables across comparative study arms.
Every vial of GHK-Cu shipped by PX1 Research bears a unique lot number linked directly to its analytical batch record. To perform a ghk-cu coa lookup, investigators can match the lot number on the vial label with our online documentation repository.
Upon inspecting a ghk cu coa, verify that the lot number printed on the certificate matches the batch identifier on the physical product. Ensure the report includes a clear chromatogram with baseline resolution, an integrated peak table detailing total purity percentage, a mass spectrum matching theoretical mass-to-charge ratios, and formal authorization signatures from the testing laboratory's Quality Assurance officer. Any discrepancy in batch numbers or analytical data should be reported immediately prior to reconstituting the reagent.
Proper reconstitutive technique is vital to preserve the chemical stability and copper coordination of GHK-Cu in laboratory settings. GHK-Cu lyophilized powder should be reconstituted using sterile, preservative-free or specialized diluents such as bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4), depending on down-stream assay requirements.
To reconstitute, allow the vial to equilibrate to room temperature before introducing the solvent along the inner glass wall of the vial. Gently swirl the container until complete dissolution is achieved; avoid vigorous vortexing to prevent protein shearing or froth formation. Because GHK-Cu contains a bound copper ion, avoid chelating agents (such as high-concentration EDTA) in stock solution buffers unless intentionally studying copper dissociation kinetics.
For long-term stability, store lyophilized GHK-Cu at -20°C or -80°C protected from light. Reconstituted stock solutions should be aliquoted into polypropylene cryovials to minimize freeze-thaw cycles and stored at -20°C for short-term preclinical applications.
PX1 Research serves academic institutions, biotechnology firms, and contract research organizations (CROs) requiring verified research-grade compounds. Our commitment to transparent analytical verification ensures that every batch of GHK-Cu meets strict standards for sequence fidelity and purity.
Laboratories conducting high-throughput screening or large-scale animal studies can establish wholesale laboratory accounts to access bulk quantities, custom lot reservations, and specialized batch analysis. All orders placed Monday through Friday ship same-day from our strategically located fulfillment centers in California and Arizona, providing rapid delivery to support ongoing research schedules.
What is a ghk-cu certificate of analysis?
A ghk-cu certificate of analysis (COA) is a lot-specific analytical document produced by an independent laboratory that certifies the chemical identity, RP-HPLC purity percentage, mass spectrometry molecular weight, and endotoxin content of a GHK-Cu research compound lot.
Where can I complete a ghk-cu coa lookup for my PX1 Research lot?
You can perform a ghk-cu coa lookup directly on the PX1 Research website by entering the specific lot number printed on your product vial label. This provides instant access to the full HPLC chromatogram, mass spectrometry readout, and endotoxin report.
What purity level should be reflected on a valid ghk cu coa?
A high-grade ghk cu coa for laboratory research should indicate a minimum purity of ≥98.0%, with premium analytical standards reaching ≥99.0% as measured by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) peak integration.
How does mass spectrometry verify a ghk-cu-coa?
Mass spectrometry (ESI-MS) measures the precise mass-to-charge ratio of the compound. On a valid ghk-cu-coa, the MS spectrum confirms the expected molecular weight of the GHK tripeptide coordinated with copper, ruling out sequence errors or uncomplexed impurities.
What are the acceptable endotoxin limits on a GHK-Cu COA?
For cell culture and animal model applications, acceptable endotoxin levels on a GHK-Cu COA typically fall below 0.5 EU/mg (or <0.1 EU/mg for high-purity lots), as determined by a Limulus Amebocyte Lysate (LAL) assay.
How should lyophilized GHK-Cu be stored in the laboratory?
Lyophilized GHK-Cu research powder should be stored at -20°C or -80°C in a dry environment protected from light. Under these conditions, the unconstituted peptide remains stable for extended periods.
What diluent should be used to reconstitute GHK-Cu for in vitro research?
GHK-Cu can be reconstituted using sterile bacteriostatic water, sterile water for injection, or standard phosphate-buffered saline (PBS, pH 7.4). Avoid buffers containing strong chelating agents like EDTA unless required by specific experimental designs.
How does GHK-Cu compare to BPC-157 in preclinical repair studies?
In preclinical literature, GHK-Cu is primarily studied for copper-mediated collagen synthesis, elastin production, and matrix remodeling, whereas BPC-157 is researched for its growth factor upregulation and angiogenic properties in soft tissue repair.
Can institutions request bulk or wholesale GHK-Cu analytical documentation?
Yes, qualified academic and institutional buyers can request comprehensive bulk analytical packages and establish dedicated supply lines through PX1 Research wholesale accounts.
Are PX1 Research GHK-Cu compounds manufactured in the USA?
Yes. PX1 Research compounds are manufactured in US-based, GMP-compliant facilities and undergo independent ISO 17025 laboratory verification prior to dispatch from California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.